Inactive Instrument
Cell MedX Corp Stock OTC Bulletin Board
Stocks
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| Market Cap | 4.65M 4.09M 3.86M 3.52M 6.58M 446M 6.63M 46.28M 17.93M 227M 17.46M 17.08M 739M | P/E 2027 * |
-11x | P/E 2028 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 4.65M 4.09M 3.86M 3.52M 6.58M 446M 6.63M 46.28M 17.93M 227M 17.46M 17.08M 739M | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 7.75x |
| Free-Float |
28.33% | Yield 2027 * |
-
| Yield 2028 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 56 | 2023-12-11 |
Yanika Silina
DFI | Director of Finance/CFO | 48 | 2014-11-23 |
| Director | Title | Age | Since |
|---|---|---|---|
George Adams
CHM | Chairman | 74 | 2024-02-25 |
Joao da Costa
BRD | Director/Board Member | 62 | 2020-06-07 |
David Jeffs
BRD | Director/Board Member | 56 | 2023-12-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.19% | +3.30% | +8.80% | +30.43% | 48.01B | ||
| +2.67% | +2.07% | +51.74% | +38.37% | 45.27B | ||
| -1.38% | +1.84% | +9.13% | +88.88% | 40.93B | ||
| +4.78% | +1.48% | +359.03% | +566.20% | 42.84B | ||
| -0.62% | -1.61% | +5.30% | +46.02% | 29.6B | ||
| +0.56% | +0.88% | +24.79% | +155.71% | 17.32B | ||
| -0.46% | +1.23% | +26.81% | +41.36% | 15.34B | ||
| +3.39% | -3.49% | - | - | 15.15B | ||
| +7.38% | +2.34% | +3.80% | - | 14.84B | ||
| Average | +0.88% | +1.02% | +61.18% | +138.14% | 29.92B | |
| Weighted average by Cap. | +0.93% | +1.56% | +77.01% | +149.53% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 600K 528K 498K 454K 849K 57.6M 855K 5.97M 2.31M 29.31M 2.25M 2.2M 95.39M |
| Net income | -510K -449K -423K -386K -722K -48.96M -727K -5.07M -1.97M -24.92M -1.91M -1.87M -81.08M | - |
| Net Debt | - | - |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















